Barcelona: 10th AD/PD Conference Hosts a Shaken, Restive Field Barcelona: Straight Talk From a Regulator on Trials in Parkinson’s Barcelona: Taking Parkinson’s Research From Movement to Mind Barcelona: What Lies Beyond Genomewide Association Studies? Barc
Tau, α-Synuclein Spread: Crazy Stuff—How Might It Work? Like Star Born of Supernova, Plaque Born of Exploded Neuron? Can Dousing PyroGlu-Aβ Treat Alzheimer’s Disease? Field Ramps Up "Mini" Mouse MRI LRRK Watchers’ Eyes Turn to Inflammation, Auto
HAI Chicago: PIB in Healthy People HAI Chicago: Can PIB Predict Cognitive Decline? HAI Chicago: PIB and Aβ Show Regional Nuances and Sleep-Wake Rhythm HAI Chicago: Not Just PIB—Other PET Tracers in Clinical Pipeline Human Amyloid Imaging 2008
HAI Seattle: Does Brain Amyloid Correlate With Sagging Metabolism? HAI Seattle: Aβ May Disrupt Brain Function in Normal Seniors HAI Seattle: Not Just Amyloid, Not Just PIB HAI Seattle: Biomarkers Closing in on AD Pathological Sequence? Human Amyloid Imagi
Toronto: Human Amyloid Imaging Conference Showcases a Maturing Field Toronto: Ah, The Devil in the Details Toronto: Last Gift to Science—Hospice Patients Validate Amyloid Ligand Toronto: Sister 18F Ligands Jostle for Primacy Toronto: HAI Amyloid Imaging C
Miami: Women Rock at Human Amyloid Imaging Meeting Miami: Amyloid in the Aging Brain—What Does It Mean? Miami: Multimodal Imaging, New Way to Test Amyloid Hypothesis Miami: Astrocytes, Antidepressants, Microbleeds, and More Miami: Updates on J-ADNI, 18F T
News Focus: 2012 Human Amyloid Imaging Conference Miami: Amyloid PET in the Clinic: What Are the Issues? Miami: Scan and Tell? Amyloid Imaging Confronts Disclosure Dilemma Miami: Can the Naked Eye Tell When a Scan Is Positive? Miami: When Does Amyloid Dep
Solanezumab Selected for Alzheimer’s A4 Prevention Trial HAI—Spotlight on Tau Tracers at Human Amyloid Imaging Meeting HAI—Amyloid Imaging in the Clinic: New Guidelines and Data HAI—Sharper Curves: Revamping a Biomarker Staging Model HAI—Standardizing Amy
Boston: Clinical Trial Results for Dimebon Unveiled Boston: Resting State MRI Shows Loss of Network Connectivity Early in AD American Academy of Neurology: 2007 Annual Meeting
Las Vegas: New Partner, New Game Plan for Lou Ruvo Brain Institute Las Vegas: AD, Risk, ApoE—Tomm40 No Tomfoolery Las Vegas: Prevention Prominent at CTAD Las Vegas: 2020 Vision—AD Prevention in 11 Years? Clinical Trials on Alzheimer’s Disease 2009
Nutrient Formulation Appears to Grease Memory Function Door Slams on RAGE Whence and Where To: History and Future of AD Therapy Trials Clinical Trials: Making “Protocols From Hell” Less Burdensome EEG: Coming in From the Margins of Alzheimer’s Research? E
Researchers Revel in C9ORF72 Advances at RNA Symposium Profilin-1 Links Cytoskeleton and RNA Aggregation in ALS The Four Stages of TDP-43 Proteinopathy Blocking a MicroRNA Slows Motor Neuron Disease in Mice Glial Cells Refine Neural Circuits Innate Immune
CTAD: Turning the Ship Around Toward Early Trials CTAD: New Data on Sola, Bapi, Spark Theragnostics Debate CTAD: Regulatory Science Gains Prominence in AD Research CTAD: Adaptive Antibody Trial to Try Bayesian Statistics CTAD: ApoE Carriers Sought for Tri
A Conference Devoted to Better Engaging Clinical Trial Volunteers Turning to the Internet for Alzheimer’s Trial Volunteers Patient Engagement in Clinical Trials